![]() |
Acta Pharmacologica Sinica 2008 January; 29 (1): 83-89; doi: 10.1111/j.1745-7254.2008.00729.x |
| Original Article | [
Full text] |
| Promotion of cell proliferation by HBXIP via upregulation of human telomerase reverse transcriptase in human mesenchymal stem cells1 |
Feng-ze WANG2, Li SHA3, Li-hong YE2,4, Xiao-dong ZHANG3,4 Departments of 2Biochemistry and 3Cancer Research, Tianjin Key Laboratory of Microbial Functional Genomics, Institute for Molecular Biology, College of Life Sciences, Nankai University, Tianjin 300071, China |
Methods: BMMS-03 cells and hMSC from the bone marrow of a 4-month-old elicited fetus, were transiently transfected with the pcDNA3-hbxip plasmid encoding the HBXIP gene and pSilencer-hbxip plasmid encoding RNA interference (RNAi) targeting HBXIP mRNA, followed by the examination of the hTERT promoter reporter gene by luciferase assay, and the detection of telomerase activity by telomeric repeat amplication protocol, respectively, as well as the expression levels of hTERT, c-Myc, and Bcl-2 by Western blot analysis.
Results: The overexpression of HBXIP led to a significant upregulation of hTERT promoter activity, telomerase activity, and the expression levels of hTERT, c-Myc, and Bcl-2 in BMMS-03 cells. RNAi targeting HBXIP mRNA produced the opposite results completely.
|
Keywords: hepatitis B X-interacting protein; human telomerase reverse transcriptase promoter; human telomerase reverse transcriptase activity; stem cells; proliferation |
| 1 Project supported by grants from the National Basic Research Program of China (973 Program, No 2007CB914800) and the National Natural Science Foundation of China (No 30670959). |
|
[
Full text] |
Copyright©APS 2009 Add: 294 Tai-Yuan Road, Shanghai 200031, China Phn: 86-21-5492-2821 Fax: 86-21-5492-2823 E-mail: aps@mail.shcnc.ac.cn |